EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitMetaanalyseOpen Access · CC BY 4.0

Efficacy and safety of continuous veno-venous hemofiltration for acute respiratory distress syndrome: a meta-analysis

Rui Wang, Sicheng Xu

Frontiers in Medicine · 17.07.2026 · 13

DOI: 10.3389/fmed.2026.1856590 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Medicine, online erschienen am 17.07.2026. Verfasst von Rui Wang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Xinjiang Medical University, Urumqi, China. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To evaluate the efficacy and safety of continuous veno-venous hemofiltration (CVVH) in patients with acute respiratory distress syndrome (ARDS) using a meta-analytic approach.

Methods

Randomized controlled trials on CVVH for ARDS were retrieved from Chinese databases (Wanfang, CNKI) as well as PubMed and Web of Science. Meta-analysis was performed using Review Manager 5.3 software on the extracted data.

Results

This meta-analysis included a total of 28 randomized controlled trials (RCTs) involving 1,739 patients with ARDS, comprising 897 cases in the CVVH group and 842 cases in the conventional treatment group. The results demonstrated that the CVVH group exhibited superior outcomes compared to the conventional treatment group in terms of oxygenation index (MD = 52.80, 95% CI [39.75, 65.84], p < 0.00001), mortality rate (OR = 0.43, 95% CI [0.34, 0.56], p < 0.00001), ICU hospitalization duration (MD = −4.88, 95% CI [−6.45, −3.31], p < 0.00001), mechanical ventilation duration (MD = −4.10, 95% CI [−5.04, −3.15], p < 0.00001), APACHE II score (MD = −3.62, 95% CI [−4.30, −2.95], p < 0.00001), VAP incidence (OR = 0.21, 95% CI [0.12, 0.36], p < 0.00001), PaO₂ (MD = 7.49, 95% CI [5.31, 9.67], p < 0.00001), PEEP (MD = −2.07, 95% CI [−2.85, −1.29], p < 0.00001), TNF- α (MD = −19.17, 95% CI [−27.77, −10.56], p < 0.0001), IL-6 (MD = −24.86, 95% CI [−31.88, −17.84], p < 0.00001), CRP (MD = −23.48, 95% CI [−39.96, −7.00], p = 0.005), PCT (MD = −2.31, 95% CI [−3.78, −0.84], p = 0.002), WBC (MD = −3.36, 95% CI [−6.30, −0.42], p = 0.03), MAP (MD = 3.57, 95% CI [0.55, 6.58], p = 0.02), HR (MD = −11.72, 95% CI [−14.07, −9.38], p < 0.00001), and EVLWI (MD = −2.61, 95% CI [−4.60, −0.62], p < 0.00001). No statistically significant differences were observed between the two groups regarding PaCO₂ (MD = −3.05, 95% CI [−7.12, 1.02], p = 0.14) or cardiac index (CI) (MD = 0.36, 95% CI [−0.89, 1.60], p = 0.57).

Conclusion

In conclusion, CVVH as an adjunctive therapy for ARDS improves oxygenation, reduces mortality, shortens ICU and ventilator days, lowers APACHE II score and heart rate, decreases VAP incidence, and exerts anti-inflammatory and fluid-removing effects. Although substantial heterogeneity and potential publication bias exist (e.g., for oxygenation index and mechanical ventilation duration), and all included studies are from China, CVVH demonstrates promising clinical value. Large-scale, multicenter RCTs are needed to confirm these findings and optimize treatment protocols.

Schlagwörter

Stichwörter der Autor:innen

acute respiratory distress syndromecritical careefficacymeta-analysisveno-venous hemofiltration

Autor:innen und Institutionen

  • Xinjiang Medical University, Urumqi, China.
  • The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.

Zitieren

APA

Wang, R., & Xu, S. (2026). Efficacy and safety of continuous veno-venous hemofiltration for acute respiratory distress syndrome: a meta-analysis. Frontiers in Medicine, 13. https://doi.org/10.3389/fmed.2026.1856590

Vancouver

Wang R, Xu S. Efficacy and safety of continuous veno-venous hemofiltration for acute respiratory distress syndrome: a meta-analysis. Frontiers in Medicine. 2026;13. doi:10.3389/fmed.2026.1856590

BibTeX
@article{Wang2026,
  author = {Wang, Rui and Xu, Sicheng},
  title = {Efficacy and safety of continuous veno-venous hemofiltration for acute respiratory distress syndrome: a meta-analysis},
  journal = {Frontiers in Medicine},
  year = {2026},
  volume = {13},
  doi = {10.3389/fmed.2026.1856590}
}
Kostenlos starten →